Rachel J. Stevens

The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition

G. Griebel, O. Bergis, C. Cohen, 2011, Pharmacology Biochemistry and Behavior.

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

I. Weiner, B. Borowsky, G. Griebel, 2011, Psychopharmacology.